[1]. L. Esserman Y. Shieh I. Thompson 2009 Rethinking screening for breast cancer and prostate cancer JAMA 302 1685–1692.

[1]. L. Esserman Y. Shieh I. Thompson 2009 Rethinking screening for breast cancer and prostate cancer JAMA 302 1685–1692.)| false
• Search Google Scholar
• Export Citation

[2]. A. Kovács L. Döbrőssy A. Budai I. Boncz A. Cornides 2007 Az emlőszűrés helyzete Magyarországon 2006- ban Orv. Hetil. 148 879–885.

[2]. A. Kovács L. Döbrőssy A. Budai I. Boncz A. Cornides 2007 Az emlőszűrés helyzete Magyarországon 2006- ban Orv. Hetil. 148 879–885.)| false
• Search Google Scholar
• Export Citation

[3]. US Preventive Services Task Force 2009 Screening for breast cancer: US Preventive Services Task Force Recommendation Statement Ann. Intern. Med. 151 716–726.

[3]. US Preventive Services Task Force 2009 Screening for breast cancer: US Preventive Services Task Force Recommendation Statement Ann. Intern. Med. 151 716–726.)| false
• Search Google Scholar
• Export Citation

[4]. C. J. Rosenquist K. K. Lindfors 1994 Screening mammography in women aged 40–49 years: analysis of costeffectiveness Radiology 191 647–650.

[4]. C. J. Rosenquist K. K. Lindfors 1994 Screening mammography in women aged 40–49 years: analysis of costeffectiveness Radiology 191 647–650.)| false
• Search Google Scholar
• Export Citation

[5]. Gøtzsche, P., Nielsen, M.: Screening for breast cancer with mammography. Cochrane database, Available at: http://www.cochrane.org/reviews/en/ab001877.html.

[5]. Gøtzsche, P., Nielsen, M.: Screening for breast cancer with mammography. Cochrane database, Available at: http://www.cochrane.org/reviews/en/ab001877.html.)| false
• Search Google Scholar
• Export Citation

[6]. P. Gøtzsche O. Olsen 2000 Is screening for breast cancer with mammography justifiable? Lancet 355 129–134.

[6]. P. Gøtzsche O. Olsen 2000 Is screening for breast cancer with mammography justifiable? Lancet 355 129–134.)| false
• Search Google Scholar
• Export Citation

[7]. L. Nystrom I. Andersson N. Bjurstam J. Frisell B. Nordenskjöld L. E. Rutqvist 2002 Long-term effects of mammography screening: updated overview of the Swedish randomized trials Lancet 359 909–919.

[7]. L. Nystrom I. Andersson N. Bjurstam J. Frisell B. Nordenskjöld L. E. Rutqvist 2002 Long-term effects of mammography screening: updated overview of the Swedish randomized trials Lancet 359 909–919.)| false
• Search Google Scholar
• Export Citation

[8]. L. Nystrom 2000 Correspondence Lancet 355 748–749.

[8]. L. Nystrom 2000 Correspondence Lancet 355 748–749.)| false
• Search Google Scholar
• Export Citation

[9]. R. Peto J. Boreham M. Clarke C. Davies V. Beral 2000 UK and USA breast cancer death down 25% in year 2000 at ages 20–69 years Lancet 355 1822.

[9]. R. Peto J. Boreham M. Clarke C. Davies V. Beral 2000 UK and USA breast cancer death down 25% in year 2000 at ages 20–69 years Lancet 355 1822.)| false
• Search Google Scholar
• Export Citation

[10]. D. A. Berry K. A. Cronin S. K. Plevritis D. G. Fryback L. Clarke M. Zelen J. S. Mandelblatt A. Y. Yakovlev J. D. Habbema E. J. Feuer 2005 Effect of screening and adjuvant therapy on mortality from breast cancer N. Eng. J. Med. 353 1784–1792.

[10]. D. A. Berry K. A. Cronin S. K. Plevritis D. G. Fryback L. Clarke M. Zelen J. S. Mandelblatt A. Y. Yakovlev J. D. Habbema E. J. Feuer 2005 Effect of screening and adjuvant therapy on mortality from breast cancer N. Eng. J. Med. 353 1784–1792.)| false
• Search Google Scholar
• Export Citation

[11]. L. Nystrom L. G. Larsson S. Wall L. E. Rutqvist I. Andersson N. Bjurstam G. Fagerberg J. Frisell L. Tabar 1996 An overview of the Swedish randomized mammography trials: total mortality pattern and the representativity of the study cohorts J. Med. Screening 3 85–87.

[11]. L. Nystrom L. G. Larsson S. Wall L. E. Rutqvist I. Andersson N. Bjurstam G. Fagerberg J. Frisell L. Tabar 1996 An overview of the Swedish randomized mammography trials: total mortality pattern and the representativity of the study cohorts J. Med. Screening 3 85–87.)| false
• Search Google Scholar
• Export Citation

[12]. H. D. Nelson K. Tyne A. Naik C. Bougatsos B. K. Chan L. Humphrey US Preventive Services Task Force 2009 Screening for breast cancer: an update for the US Preventive Services Task Force Ann. Intern. Med. 151 727–737.

[12]. H. D. Nelson K. Tyne A. Naik C. Bougatsos B. K. Chan L. Humphrey US Preventive Services Task Force 2009 Screening for breast cancer: an update for the US Preventive Services Task Force Ann. Intern. Med. 151 727–737.)| false
• Search Google Scholar
• Export Citation

[13]. B. Döbrőssy A. Kovács A. Budai A. Cornides L. Döbrőssy 2007 A szűrés nemkívánatos lélektani mellékhatásai Orv. Hetil. 148 1707–1711.

[13]. B. Döbrőssy A. Kovács A. Budai A. Cornides L. Döbrőssy 2007 A szűrés nemkívánatos lélektani mellékhatásai Orv. Hetil. 148 1707–1711.)| false
• Search Google Scholar
• Export Citation

[14]. S. Zackrisson I. Andersson L. Janzon J. Manjer J. P. Garne 2006 Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study BMJ 332 689–692.

[14]. S. Zackrisson I. Andersson L. Janzon J. Manjer J. P. Garne 2006 Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study BMJ 332 689–692.)| false
• Search Google Scholar
• Export Citation

[15]. P. H. Zahl J. Moehlen H. G. Welch 2008 The natural history of invasive breast cancers detected by screening mammography Arch. Intern. Med. 168 2311–2316.

[15]. P. H. Zahl J. Moehlen H. G. Welch 2008 The natural history of invasive breast cancers detected by screening mammography Arch. Intern. Med. 168 2311–2316.)| false
• Search Google Scholar
• Export Citation

[16]. J. Bonneterre V. Diéras 2007 Cancéro Guide, Sein Margaux Orange Paris.

[16]. J. Bonneterre V. Diéras 2007 Cancéro Guide, Sein Margaux Orange Paris.)| false
• Search Google Scholar
• Export Citation